Te Pātaka Whaioranga – Pharmac is calling for applications for medicines to treat rare disorders. These will be considered at the next meeting of the Rare Disorders Advisory Committee meeting in May 2024.
A recent spike in COVID-19 cases is a reminder for people who are at high-risk to make sure they’re up to date with their COVID-19 booster and to use antiviral medications early if they are infected with the virus.
Source
Media release from Te Whatu Ora - Health New Zealand
A consultation document explaining the Pharmacy Council’s proposed Disciplinary levy and APC fee increases has been released today with submissions due no later than 9.00am Monday, 11 December 2023
The Pharmaceutical Society of New Zealand (PSNZ) is forming a national Education Advisory Group (EAG) to ensure educators and participants involved in PSNZ’s pharmacy education and training have an opportunity to discuss and provide feedback on educational issues, PSNZ President Rhiannon Braund announced today
Te Pātaka Whaioranga – Pharmac is consulting on a proposal to fund testosterone gel without restrictions as an additional testosterone treatment for those who need it.
A new resource to help countries self-assess the adequacy of their regulatory systems to support pharmacy interventions to prevent the harms of substandard and falsified (SF) medicines is launched by the International Pharmaceutical Federation (FIP) today.
Travellers who may have come into contact with a measles case on recent flights between the United States, Auckland and New Plymouth are asked to urgently check the latest public health information on locations of interest – and contact Healthline on 0800 611 116 without delay if they meet the risk criteria.
Source
Media release from Te Whatu Ora - Health New Zealand
A person has been confirmed with measles in Taranaki, after returning to New Zealand from overseas. This follows recent cases linked to a person from Northland and is the thirteenth measles case so far this year.
The seasonally adjusted unemployment rate was 3.9 percent in the September 2023 quarter, compared with 3.6 percent last quarter, according to figures released by Stats NZ today.
Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes